Molecular map that reveals insights into the genetic drivers of chronic lymphocytic leukemia

Written By : Isra Zaman

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-08-06 03:30 GMT | Update On 2022-08-06 03:30 GMT

To provide a more thorough understanding of the biological underpinnings of CLL and its molecular subtypes, scientists set out to construct a map from the largest CLL dataset to date.

A newly constructed map of the landscape of genetic changes in chronic lymphocytic leukemia (CLL), a type of cancer of the blood and bone marrow that exists in diverse forms and arises from various causes, provides a better understanding of this complex malignancy that could lead to more accurate prognoses for patients, improved diagnostics, and novel treatments. The work is published in Nature Genetics

To build the CLL map, the team analyzed variations in genetic sequences, gene expression patterns, and chemical modifications to DNA—or genomic, transcriptomic, and epigenomic data—from 1,148 patients.

The scientists identified 202 genes (109 of which were novel) that when mutated could potentially drive CLL, and they refined the characterization of subtypes of CLL with distinct genomic characteristics and prognoses. Beyond genetic sequences, the expression patterns of certain genes further subcategorized CLL and provided valuable prognostic information.

Patients' clinical outcomes were associated with a combination of genomic, transcriptomic, and epigenomic features—so that integrating these data could predict a patient's likelihood of experiencing remission versus developing more advanced cancer.

Ref:

Catherine Wu et. al, Molecular map of chronic lymphocytic leukemia and its impact on the outcome, Nature Genetics, 4-Aug-2022, DOI: 10.1038/s41588-022-01140-w

Full View

Article Source : Nature Genetics

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Isra Zaman

Isra Zaman is a Life Science graduate from Daulat Ram College, Delhi University, and a postgraduate in Biotechnology from Amity University. She has a flair for writing, and her roles at Medicaldialogues include that of a Sr. content writer and a medical correspondent. Her news pieces cover recent discoveries and updates from the health and medicine sector. She can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Molecular map that reveals insights into the genetic drivers of chronic lymphocytic leukemia

Similar News

Scientists discover unexpected link between gray hair and cancer risk

mRNA COVID vaccines may improve survival rates in cancer patients, Study shows

Are cancer surgeries unknowingly eliminating the body's natural defense against cancer? Study sheds light

Study Finds Fatty Acids as Key Driver of Triple-Negative Tumor Growth

Women with This Common Condition Face Higher Risk of Gynaecological Cancer: Systematic Review Finds

New Imaging Technique Detects Prostate Cancer Recurrence with 70 Percent Accuracy: Study Finds

Is Social Isolation an Overlooked Risk Factor in Cancer Mortality? A New Study Explores

Importance of Identifying High-Risk Node-Positive Patients in EBC